Table 3 Summary of statistical model results
Outcome | Low omega-3 group | |
|---|---|---|
Lung function | ||
FVC | \(\to\) | \(\uparrow_{L0-2\;and\;5dMA}\) |
FEV1 | \(\to\) | \({\uparrow }_{5dMA}\) |
Blood lipids | ||
Total cholesterol | \(\to\) | \({\downarrow }_{L2}\) |
HDL | \(\to\) | \(\downarrow_{L1-2\;and\;5dMA}\) |
LDL | \(\to\) | \({\downarrow }_{L2}\) |
Coagulation / fibrinolysis factors | ||
vWF | \({\uparrow }_{L0}\) | \(\uparrow_{L1\;and\;5dMA}\) |
D-dimer | \({\uparrow }_{L0}\) | \(\to\) |
Vascular function | ||
FMD | \(\to\) | \(\uparrow_{L1-2\;and\;5dMA}\) |
ET-1 | \({\downarrow }_{5dMA}\) | \(\downarrow_{L3-4\;and\;5dMA}\) |
Heart rate variability | ||
HFn | \(\to\) | \({\downarrow }_{L3}\) |
LF/HF | \(\to\) | \({\uparrow }_{L3}\) |
VLF | \({\downarrow }_{L0}\) | \(\to\) |